V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003745 | 210007020 | 1.57 | 62.4 | Palliative (P) | 2018-02-08 | 2018-02-24 | EC | 02 | N | EC | 101476880 |
| 210003746 | 210007021 | null | null | null | 2017-08-31 | 2017-09-14 | Letrozole + Palbociclib | null | null | LETROZOLE + PALBOCICLIB | 100680941 |
| 210003749 | 210007024 | null | null | null | null | 2019-03-25 | FEC + DOCETAXEL | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101397605 |
| 210003750 | 210007025 | null | 82 | 03 | null | 2018-07-26 | Fulvestrant + Palbociclib | 02 | N | ROSCO TRIAL | 101617762 |
| 210003752 | 210007027 | 1.66 | null | Palliative (P) | 2018-10-13 | 2018-11-04 | Letrozole + Palbociclib | N | N | CAPECITABINE | 100962024 |
| 210003753 | 210007028 | null | 56.6 | null | 2017-01-25 | 2017-02-01 | Paclitaxel+Trastuzumab wkly Maint | N | null | PACLITAXEL + TRASTUZUMAB | 100556658 |
| 210003755 | 210007030 | 1.72 | 73.5 | Palliative (P) | null | 2016-03-31 | null | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100206801 |
| 210003762 | 210007036 | 1.71 | 68.2 | Adjuvant (A) | 2017-12-12 | 2017-12-15 | FEC + DOCETAXEL | 02 | N | FEC + DOCETAXEL | 101823616 |
| 210003763 | 210007037 | null | 77.6 | null | 2018-09-16 | 2018-09-28 | FEC + DOCETAXEL | N | null | FEC + DOCETAXEL | 101207248 |
| 210003765 | 210007039 | 1.64 | null | Adjuvant (A) | 2017-04-19 | 2017-04-20 | CARBOPLATIN + GEMCITABINE | N | N | CARBOPLATIN | 101794773 |
| 210003770 | 210007043 | null | null | Palliative (P) | 2018-08-27 | 2018-08-29 | FEC + DOCETAXEL | 02 | N | FEC + DOCETAXEL | 101804234 |
| 210003772 | 210007044 | 1.51 | 54 | Adjuvant (A) | null | 2017-09-14 | Letrozole + Palbociclib | null | N | CARBOPLATIN + DOCETAXEL | 101069244 |
| 210003773 | 210007045 | 1.57 | 59 | null | 2022-02-04 | 2022-02-16 | TCH (21 day Trastuzumab) Maint | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL + TRASTUZUMAB | 101108908 |
| 210003774 | 210007046 | 1.61 | 68.1 | Neo-adjuvant (N) | 2020-03-23 | 2020-04-01 | null | null | N | CARBOPLATIN + GEMCITABINE | 101314271 |
| 210003775 | 210007047 | 1.58 | 72.9 | null | 2018-10-14 | 2018-10-29 | EC | 02 | null | EC | 101226672 |
| 210003777 | 210007049 | null | null | null | null | 2019-01-23 | Paclitaxel+Trastuzumab wkly Maint | N | null | PACLITAXEL + TRASTUZUMAB | 101028848 |
| 210003779 | 210007051 | 1.55 | 48.6 | null | 2017-02-13 | 2017-02-13 | FEC 60 or 75 | N | null | FEC | 101717009 |
| 210003783 | 210007055 | 1.64 | 58.4 | Neo-adjuvant (N) | null | 2016-12-16 | FEC + DOCETAXEL | null | N | FEC + DOCETAXEL | 100235204 |
| 210003791 | 210007061 | 1.71 | 99.6 | null | 2020-09-12 | 2020-09-24 | Carboplatin + Pemetrexed | 02 | N | FEC + TRASTUZUMAB | 100632682 |
| 210003794 | 210007064 | 1.63 | 67.6 | Adjuvant (A) | null | 2019-11-25 | null | null | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101774771 |
| 210003797 | 210007066 | null | 69.2 | null | 2019-07-07 | 2019-07-18 | PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100216251 |
| 210003801 | 210007068 | null | null | null | 2020-01-29 | 2020-01-29 | Trial Unspecified | 02 | null | FULVESTRANT + PALBOCICLIB | 100609950 |
| 210003803 | 210007070 | 1.69 | 59.7 | Palliative (P) | 2017-10-16 | 2017-10-24 | FEC | null | N | FEC | 100784792 |
| 210003811 | 210007077 | 1.55 | 42.4 | null | 2016-01-08 | 2016-04-29 | FEC 60 or 75 | N | null | FEC | 100844377 |
| 210003812 | 210007078 | 1.69 | 0 | Palliative (P) | null | 2017-08-12 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 100552101 |
| 210003814 | 210007080 | 1.68 | 96.7 | null | null | 2016-08-26 | CARBOPLATIN | 01 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100731635 |
| 210003818 | 210007083 | null | null | null | 2019-09-08 | 2019-12-10 | FEC 60 or 75 | N | null | FEC | 101420244 |
| 210003820 | 210007085 | 1.61 | 75.8 | Palliative (P) | 2017-07-31 | 2017-08-03 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | 02 | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 100179563 |
| 210003821 | 210007086 | 1.7 | 64 | null | 2019-03-17 | 2019-04-08 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101309940 |
| 210003825 | 210007089 | 1.65 | 61.45 | Palliative (P) | 2016-08-17 | 2016-08-24 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 100247673 |
| 210003827 | 210007091 | 1.63 | 59 | Palliative (P) | 2019-04-28 | 2019-08-12 | FEC + DOCETAXEL | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100114946 |
| 210003830 | 210007094 | 1.56 | 106.5 | Adjuvant (A) | 2018-03-11 | 2018-05-21 | FEC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101383942 |
| 210003832 | 210007095 | 1.65 | 52.6 | Palliative (P) | 2016-07-22 | 2016-07-30 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100586130 |
| 210003836 | 210007098 | 0 | 60.4 | null | null | 2020-02-06 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100323428 |
| 210003839 | 210007101 | null | null | null | null | 2018-03-20 | EC | null | null | EC | 101616051 |
| 210003844 | 210007103 | 1.68 | 62.3 | null | 2017-01-13 | 2017-01-21 | FEC 100 | null | null | FEC | 100348651 |
| 210003845 | 210007104 | 1.67 | 66 | Neo-adjuvant (N) | 2018-02-10 | 2018-02-17 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 100474186 |
| 210003848 | 210007107 | 1.6 | 0 | Palliative (P) | null | 2018-06-29 | FEC 100 | 02 | N | FEC | 100349970 |
| 210003849 | 210007108 | 1.64 | 54.2 | null | null | 2018-12-26 | EC | N | null | EC | 100363280 |
| 210003850 | 210007109 | 1.47 | 58 | Palliative (P) | 2019-06-28 | 2019-07-16 | EC | 02 | N | EC | 100865385 |
| 210003851 | 210007110 | 1.61 | 87.5 | null | 2019-11-10 | 2020-02-16 | CAPECITABINE + CARBOPLATIN | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101793615 |
| 210003852 | 210007111 | null | 59.8 | Adjuvant (A) | 2018-04-29 | 2018-05-20 | null | null | N | CARBOPLATIN + DOCETAXEL | 100647356 |
| 210003855 | 210007113 | 1.47 | 59 | null | 2021-01-24 | 2021-02-03 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101448000 |
| 210003858 | 210007115 | 1.66 | 55.3 | Adjuvant (A) | null | 2016-03-10 | null | N | N | LETROZOLE + PALBOCICLIB | 101594501 |
| 210003863 | 210007118 | null | null | null | 2017-04-29 | 2017-05-11 | FEC + DOCETAXEL | N | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100867305 |
| 210003866 | 210007121 | 1.6 | 82.7 | Neo-adjuvant (N) | null | 2019-08-25 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100727861 |
| 210003867 | 210007122 | 1.67 | 53.4 | Palliative (P) | 2018-07-19 | 2018-08-08 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101126595 |
| 210003868 | 210007123 | null | null | null | 2017-05-09 | 2017-05-19 | EC | N | null | EC | 100115007 |
| 210003869 | 210007124 | 1.69 | 81 | Adjuvant (A) | 2017-04-12 | 2017-04-21 | FEC 100 | 01 | null | FEC | 100691336 |
| 210003870 | 210007125 | 1.6 | 95.7 | Adjuvant (A) | 2017-02-11 | 2017-03-05 | TRASTUZUMAB EMTANSINE | N | Y | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101050368 |